Coronavirus: why combining the Oxford vaccine with Russia's Sputnik V vaccine could make it more effective

Jim Barber/Shutterstock When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of the vaccine at stopping people developing symptomatic COVID-19, two weeks after the second dose, was 70%. But this wasn’t the whole picture. This figure was based on averagingContinue Reading

Fitter, better rested, more appreciative: research reveals the positive changes experienced by some during lockdown

Dudarev Mikhail/Shutterstock National lockdowns have been the most profound and significant public health interventions within living memory. They have been difficult socially and economically, and have negatively affected people’s health in many different ways. But for some people lockdowns have provided an unexpected opportunity to make positive changes to theirContinue Reading

Business debt: hidden advantage for giant firms means economy has been K-shaped for decades

Ladders for us, snakes for you. Ratthaphong Ekariyasap When the COVID-19 pandemic first hit, it seemed like the day of reckoning for over-stretched corporate borrowers was finally at hand. For years, pundits and policymakers had been warning about a dangerous build-up of the debt of “non-financial firms”, meaning all thoseContinue Reading